US Patent Issued to Ribon Therapeutics on July 29 for "Solid forms of a PARP7 inhibitor" (Chinese, American Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,421, issued on July 29, was assigned to Ribon Therapeutics Inc. (Cambridge, Mass.).

"Solid forms of a PARP7 inhibitor" was invented by Melissa Marie Vasbinder (Newton, Mass.), Laurie B. Schenkel (Somerville, Mass.), Kerren Kalai Swinger (Lexington, Mass.), Kevin Wayne Kuntz (Woburn, Mass.), Jun Xu (Hangzhou, China), Meng Jiang (Suzhou, China) and Xin He (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to solid forms of the poly(ADP-ribose) polymerase 7 (PARP7) inhibitor 5-[[(2S)-1-(3-oxo-3-[4-[5-(trifluoromethyl)pyrimidin-2-yl]piperazin-1-yl]propoxy)propan-2-yl]amino]-4-(trifluoromethyl)-2,3-dihydropyridazi...